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Abstract 
Background: Precise nucleosome positioning is an increasingly recognized feature of promoters and enhancers, 
reflecting complex contributions of DNA sequence, nucleosome positioning, histone modification and transcription 
factor binding to enhancer activity and regulation of gene expression. Changes in nucleosome position and occu‑
pancy, histone variants and modifications, and chromatin remodeling are also critical elements of dynamic tran‑
scriptional regulation, but poorly understood at enhancers. We investigated glucocorticoid receptor‑associated (GR) 
nucleosome dynamics at enhancers in acute lymphoblastic leukemia.
Results: For the first time, we demonstrate functionally distinct modes of nucleosome remodeling upon chromatin 
binding by GR, which we term central, non‑central, phased, and minimal. Central and non‑central remodeling reflect 
nucleosome eviction by GR and cofactors, respectively. Phased remodeling involves nucleosome repositioning and 
is associated with rapidly activated enhancers and induction of gene expression. Minimal remodeling sites initially 
have low levels of enhancer‑associated histone modification, but the majority of these regions gain H3K4me2 or 
H3K27Ac to become de novo enhancers. Minimal remodeling regions are associated with gene ontologies specific 
to decreased B cell number and mTOR inhibition and may make unique contributions to glucocorticoid‑induced 
leukemia cell death.
Conclusions: Our findings form a novel framework for understanding the dynamic interplay between transcrip‑
tion factor binding, nucleosome remodeling, enhancer function, and gene expression in the leukemia response to 
glucocorticoids.
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Background
Glucocorticoids have been mainstays of treatment for a 
variety of malignant, autoimmune, and inflammatory 
diseases for many decades. Glucocorticoids are critical 
components of therapy for acute lymphoblastic leuke-
mia (ALL), and resistance to glucocorticoid-induced cell 
death is associated with poor prognosis in childhood 
ALL [1, 2]. Dexamethasone is a widely used synthetic 
glucocorticoid that binds to the glucocorticoid receptor 
(GR) in the cytosol and induces receptor dimerization 
and nuclear translocation. Like other nuclear hormone 
receptors such as androgen receptor (AR) and estro-
gen receptor (ER), ligand-bound GR engages chroma-
tin and acts as a transcription factor. The signaling and 
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transcriptional responses of lymphoid cells to gluco-
corticoids have been subject to intensive study, yet the 
chromatin changes linking GR binding to transcriptional 
changes remain incompletely understood. We set out to 
explore the dynamics of dexamethasone-induced chro-
matin remodeling at enhancers in the RS4; 11 B cell ALL 
cell line.
Enhancers are generally defined as non-promoter DNA 
elements that contribute to modulation of gene expres-
sion. The human genome is estimated to harbor hundreds 
of thousands enhancers, and the enhancers participating 
in transcriptional regulation differ extensively among 
cell types and stages of differentiation. Among the many 
unresolved questions surrounding enhancers are those of 
how nucleosome positioning and chromatin remodeling 
contribute to their modulation of gene expression [3]. 
In mammalian cells, nucleosome positioning has largely 
been studied at promoters. The transcriptional start 
sites of actively transcribed genes are characterized by 
a nucleosome free region. This nucleosome-free region 
is flanked by short arrays of 3–5 well-positioned nucle-
osomes, often described as phased [4, 5]. More recently, 
Gaffney et al. have described well-positioned nucleosome 
arrays flanking transcription factor binding sites within 
mammalian enhancers [6, 7]. In comparison, nucleosome 
dynamics remain far more mysterious. Although often 
depicted as tiny spools around which DNA is wound, 
nucleosomes bind DNA transiently [8]. The likelihood 
that a given segment of DNA is nucleosome-occupied 
at any given moment is thought to be affected by many 
factors, including DNA sequence, transcription fac-
tor binding, histone modifications and variants, as well 
as ATP-dependent chromatin remodeling [9, 10]. One 
obstacle to better understanding nucleosome dynam-
ics is the size of mammalian genomes. High-resolution, 
genome-wide nucleosome positioning studies typically 
utilize micrococcal nuclease (MNase) digestion of total 
native chromatin, followed by deep sequencing of result-
ing DNA fragments [11]. The number of sequencing 
reads required by this method remains prohibitively high 
for experiments aimed at comparisons of nucleosome 
position and occupancy among multiple conditions or at 
individual genomic locations.
Many groups have circumvented this difficulty by 
measuring chromatin “accessibility” typified by hyper-
sensitivity to cleavage by DNaseI (DHS) or insertion of 
a transposon (ATAC-Seq). These techniques require far 
fewer sequencing reads than MNase-Seq, and chroma-
tin accessibility is often used to approximate decreased 
nucleosome occupancy with relatively low resolution 
and sensitivity. Although DHS offers limited insights into 
nucleosome dynamics, it identifies active enhancers and 
promoters very well. Increased DHS is a widely accepted 
indicator of enhancer activation, and many groups have 
developed computational models that use changes in 
DHS to predict transcription factor binding [12–15].
Active enhancers are also characterized by histone modi-
fications that include histone 3 lysine 4 mono- and di-meth-
ylation (H3K4me1 and H3K4me2), and H3K27 acetylation 
[16, 17]. He et  al. employed chromatin immunoprecipita-
tion of H3K4me2 and sequencing (ChIP-Seq) to interrogate 
nucleosome dynamics associated with AR and ER bind-
ing to chromatin [12,  18]. Like DHS, ChIP-Seq requires 
relatively small numbers of sequencing reads to provide 
genome-wide information about active enhancers. Moreo-
ver, ChIP-Seq performed on MNase-digested native chro-
matin affords a high-resolution assessment of nucleosome 
position that is well suited to studying nucleosome dynam-
ics. Nucleosome remodeling has long been known to be a 
critical component of GR-mediated transcriptional modula-
tion. GR binds directly to the SWI/SNF chromatin remod-
eling complex, and the ATP-dependent activity of SWI/SNF 
is necessary for maximal transcriptional activation by GR 
[19, 20]. Inhibition of the SWI/SNF ATPase (SMARCA4) 
reveals both SMARCA4-dependent and -independent 
glucocorticoid-induced DHS and gene expression changes, 
suggesting diverse remodeling requirements [21, 22].
We wished to better understand nucleosome dynam-
ics and their relationships to transcription factor binding, 
enhancer activity, and gene expression. We performed 
ChIP-Seq for GR and multiple enhancer-defining histone 
modifications, as well as DHS and gene expression analy-
sis both before and after the addition of dexamethasone. 
Using a number of open-source computational packages, 
we have developed an analytic approach to ChIP-Seq that 
captures rapid changes in nucleosome position and occu-
pancy associated with chromatin binding by GR. We find 
that nucleosome remodeling is highly variable among GR 
binding sites, but can be computationally resolved into 
four predominant modes that we have dubbed “central”, 
“non-central”, “phased”, and “minimal”. Moreover, each 
class of nucleosome remodeling represents functionally 
distinct contributions to enhancer activation and changes 
in gene expression. We propose that patterns of nucleo-
some remodeling offer important new insights into 
dynamic changes of the enhancer landscape and tran-
scriptional outcomes following glucocorticoid treatment 
in ALL.
Results and discussion
GR binding is not restricted to enhancers or DHS sites
We first sought to identify enhancers in the RS4; 11 acute 
lymphoblastic leukemia cell line, and to characterize GR 
binding with respect to this existing chromatin land-
scape. We performed ChIP-Seq of GR and three differ-
ent chromatin features typically used to define enhancers 
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(H3K4me2, H3K27Ac, and DHS). Cells were cultured in 
charcoal-dextran-treated serum for 2  days prior to each 
experiment, effectively depriving them of hormone expo-
sure. GR ChIP-Seq was performed on fixed and sonicated 
chromatin, whereas histone modification ChIP-Seq was 
performed on native chromatin fragmented by MNase 
digestion. As expected, very few GR–chromatin inter-
actions were detected in cells not treated with dexa-
methasone. In contrast, 1  h after treatment with 10  nM 
dexamethasone, 9058 GR binding events were detected, 
with virtually no overlap between binding sites in the 
unstimulated and dexamethasone-stimulated cells. As in 
other cell types, promoter-bound GR peaks in RS4; 11 are a 
small minority (5.3 %). Among GR binding sites, we found 
that 46 % occur at enhancers having all three marks. We 
find that 45 % of GR binding events in RS4; 11 cells occur 
at sites not having pre-existing DHS. Additionally, 13 % of 
GR binding occurs at sites bearing none of the canonical 
enhancer marks, where GR may function as a true pioneer 
factor (Fig.  1a). Prior studies have suggested that acces-
sible chromatin (DHS) is largely required for GR to bind 
[21–23]. Many different experimental conditions and com-
putational methods have been used to measure DHS, and 
disparities between our findings and those of other groups 
may simply reflect this methodologic variability.
Decreased nucleosome occupancy precedes GR binding 
within enhancers
We wished to examine how nucleosome occupancy, in 
addition to DNA motif and enhancer chromatin marks, 
contributes to determining where GR will bind. Using the 
MNase-digested input DNA from our histone modifica-
tion ChIP-Seq experiments, we find that average nucleo-
some occupancy in hormone-deprived cells is specifically 
decreased at sites that will subsequently bind GR upon 
dexamethasone exposure. To examine the cell type speci-
ficity of this localized nucleosome depletion, we used 
publicly available GR ChIP-Seq data for the A549 lung 
carcinoma cell line from the ENCODE project [24–26] 
(filename at UCSC Genome Browser: wgEncodeAwgTfb-
sHaibA549GrPcr1xDex50nmUniPk.narrowPeak.gz). On 
average, GR binding sites unique to A549 do not show 
nucleosome depletion in RS4; 11 (Fig.  1b, top panel). 
Notably, decreased nucleosome occupancy character-
izes GR binding sites within enhancers (having H3K4me2 
and/or H3K27Ac), but not those that will occur at sites 
that lack pre-existing enhancer marks, which are actu-
ally characterized by increased nucleosome occupancy 
centered over the future GR binding site (Fig. 1b, middle 
panel). We next asked whether the nucleosome deple-
tion seen at enhancer GR binding sites is restricted to the 
DHS sites. Globally, enhancers demonstrate below-aver-
age nucleosome occupancy, consistent with an “open” 
state that is more sensitive to MNase digestion. We found 
that, on average, sites without DHS have a small degree 
of focal nucleosome depletion prior to GR binding 
(Fig. 1b, bottom panel). Nucleosome occupancy is lower 
at sites of DHS, not just centrally, but for >1.5 kb flanking 





































































Fig. 1 GR binding relative to enhancers and nucleosome‑depleted regions. a Venn diagram illustrating the binding of GR peaks within the 
enhancer landscape of unstimulated cells (labeled as NoStim). Of the 9058 GR peaks detected by ChIP‑Seq after 1 h of dexamethasone stimulation, 
45 % bind regions without prior DHS, and 13 % bind regions lacking any prior enhancer marks. b Signal profiles of nucleosome occupancy (normal‑
ized signal of MNase‑digested ChIP‑Seq input DNA) in a 3‑kb window surrounding GR summits
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Modified ChIP‑Seq analysis
We next sought to examine the dynamics of nucleosome 
positioning and occupancy around GR binding sites in 
RS4; 11 cells. We predicated these analyses on histone 
modification ChIP-Seq of MNase-digested native chro-
matin to identify and enrich for enhancer DNA as well 
as limit the necessary depth of sequencing required to 
assess nucleosome position. To focus on nucleosome 
dynamics, we first calculated a “delta” ChIP-Seq signal 
by subtracting the normalized ChIP signal for unstimu-
lated cells from the normalized ChIP signal for dexa-
methasone-treated cells. This transformation emphasizes 
the changes in ChIP signal occurring in response to the 
hour-long dexamethasone stimulus (Fig.  2a). When we 
examined the average H3K4me2 signal across a 3-kb win-
dow centered on the summit of all GR binding peaks, we 
found that global ChIP-Seq profiles before and after GR 
binding closely resemble those reported for AR (Fig. 2c) 
[18]. The average deltaH3K4me2 signal provides an alter-
native visualization (Fig.  2d, blue line) demonstrating 
a central depletion in response to dexamethasone hav-
ing a width of ~450 bp. This is consistent with previous 
descriptions of H3K4me2 changes in response to tran-
scription factor binding, which have been described as 
a nucleosome-depleted region (NDR), and suggests that 
both our data and our delta signal transformation faith-
fully recapitulate prior results [12, 18].
Our primary aim was to understand nucleosome 
remodeling, a term we use to describe changes in nucleo-
some occupancy, nucleosome positioning, or both. How-
ever, a decrease in H3K4me2 signal may result from 
methylation (i.e., transformation to H3K4me3) or dem-
ethylation (i.e., transformation to H3K4me1 or unmeth-
ylated H3K4), as well as nucleosome remodeling. In an 
effort to mitigate the changes in ChIP-Seq signal result-
ing from histone modification, we calculated the sum of 
the deltaH3K4me1, deltaH3K4me2, and deltaH3K4me3 
signals, henceforth referred to as the deltaH3K4meth-
yls signal. The result of this summation is exemplified in 
Fig.  2b. At some sites, the deltaH3K4methyls signal has 
the same general shape as its component signals (Fig. 2b, 
top panel). Where the deltaH3K4me1, deltaH3K4me2, 
and/or deltaH3K4me3 tracks show subtle or discord-
ant changes (Fig. 2b, bottom panel), the deltaK4methyls 
transformation smoothes signal and improves signal-to-
noise ratio. The average deltaH3K4methyls signal across 
GR binding summits has the same shape and width of 
NDR as the deltaH3K4me2 signal (Fig. 2d, red line).
Heterogeneous and asymmetric nucleosome remodeling 
accompanies GR binding
We next wished to assess the relationship between the 
deltaH3K4methyls ChIP-Seq signal and changes in 
nucleosome occupancy. We performed deep sequencing 
of the MNase-digested input chromatin that was used for 
our ChIP-Seq (4.5–5 × 108 reads/condition). As seen in 
Fig. 2c, the normalized MNase signal averaged across all 
GR binding sites shows decreased central nucleosome 
occupancy corresponding to the decreased H3K4me2 
ChIP-Seq signal in both unstimulated and dexametha-
sone-stimulated cells. However, the deltaMNase signal 
(Fig.  2d, black line) has low signal-to-noise ratio. We 
next examined a heatmap of the deltaH3K4methyls sig-
nal (Fig.  3a). This shows the expected loss of ChIP-Seq 
signal overlying the summit of GR binding peaks. Also 
apparent is significant variability in the width and posi-
tion of decreased signal relative to the GR summit. We, 
therefore, performed k-means clustering to partition GR 
binding sites according to the magnitude and position of 
change in ChIP-Seq signal. Results of k-means clustering 
(k =  27) of the deltaH3K4methyls signal in a 3-kb win-
dow centered on the GR binding summit are illustrated 
in Fig. 3b.
As expected, clustering reveals several groups (clus-
ters 1, 6, 7, 8, etc.) distinguished by subtle shifts in the 
location of their central signal loss. Strikingly, clustering 
also reveals previously unrecognized patterns of nucleo-
some remodeling occurring at and near GR binding sites. 
When these clusters are applied to the deltaMNase sig-
nal (Fig. 4), we see that decreased nucleosome occupancy 
closely mirrors the “nucleosome depleted region” of the 
deltaH3K4methyls signal.
Classifying patterns of GR‑associated nucleosome 
remodeling
As seen in Fig. 4, many clusters have a very similar sig-
nal shape and are distinguished by position relative to 
the GR binding summit. We, therefore, re-classified 
individual clusters into distinct patterns of nucleosome 
dynamics (illustrated schematically in Fig.  3c), defined 
as follows. Central remodeling overlaps the GR bind-
ing peak and alters the depth and/or width of the NDR 
(Fig.  4a, signal profiles). Non-central remodeling does 
not overlap the GR binding peak and affects the occu-
pancy/position of one or more nucleosomes flanking 
the NDR (Fig.  4b, signal profiles). Phased remodeling 
occurs at a minority of sites, where distinct and alternat-
ing peaks and valleys of nucleosome remodeling flank-
ing the GR peak are apparent (Fig.  4c, signal profiles). 
Based upon these patterns, we grouped the GR binding 
sites into four “modes” of remodeling. In the “central 
mode”, changes in H3K4methyls signal are restricted 
to the region occupied by GR. Within the “non-central 
mode”, changes in H3K4methyls are seen in regions not 
occupied by GR. The “phased mode” shows remodeling 
of multiple flanking nucleosomes in addition to that 
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overlapping the GR binding peak. The “minimal mode” 
represents all sites of GR binding not classified as cen-
tral, non-central, or phased and shows relatively small 
changes in H3K4methyls (4D, signal profile). Having 
thus defined these four modes of nucleosome remode-
ling, we set out to test whether they demonstrate func-
tionally distinct relationships between GR binding, 
nucleosome remodeling, enhancer activation, and mod-
ulation of gene expression.
Four modes of nucleosome remodeling capture distinct 
subsets of GR binding and active enhancers
For each GR peak, we examined a 3-kb window centered 
on its summit. By measuring the area under the curve, 
we were able to capture changes in ChIP-Seq signal 
reflecting both the height and width of the signal peak. 
We first evaluated the GR binding and enhancer prop-
erties of sites belonging to each mode of nucleosome 
remodeling. The degree of GR binding differs dramati-
cally between modes (Fig. 5a). Sites of phased remodeling 
have very large GR peaks and more commonly con-
tain a canonical glucocorticoid response element (GRE, 
Fig.  5b). On average, sites of minimal remodeling have 
small GR peaks, yet the range of peak sizes is very broad.
Prior to GR binding, the enhancers belonging to each 
mode of remodeling also have very different properties. 
In unstimulated cells, regions that will later demon-
strate non-central remodeling have the highest H3K27Ac 
and most frequent DHS. In contrast, sites of minimal 















































































Fig. 2 Definition and validation of deltaH3K4methyls signal. a Snapshot demonstrating how deltaH3K4me2 track is defined—normalized H3K4me2 
ChIP‑Seq signal from unstimulated cells is subtracted from that of dexamethasone‑stimulated cells, emphasizing the pattern of ChIP‑Seq signal 
change at this GR binding site. b Snapshots demonstrating how the deltaH3K4methyls track is defined. At many sites, the summed signal has the 
same shape as its components (upper panel), while at others the deltaH3K4methyls track resolves discordancies between component signals (lower 
panel). c Aggregate signal profile of normalized H3K4me2 ChIP‑Seq signal from unstimulated (solid blue) and dexamethasone‑stimulated (solid red) 
cells in a 3‑kb window surrounding all GR summits. Normalized MNase‑Seq signal from unstimulated (dashed blue) and dexamethasone‑stimulated 
(dashed red) cells is overlaid. d Aggregate signal profile of deltaH3K4me2 (blue) versus deltaH3K4methyls (red) versus deltaMNase (black) in a 3‑kb 
window surrounding all GR summits





































































schematic of nucleosomes occupying chromatin
schematic of “delta” heatmap
increased signal after Dex
decreased signal after Dex
NoStim
Dex
schematic of signal profile
Fig. 3 K‑means clustering resolves deltaH3K4methyls signal into diverse patterns of nucleosome remodeling. a Heatmap of deltaH3K4methyls 
signal in a 3‑kb window surrounding all GR summits. b Heatmaps representing the 27 k‑means clusters. Color scale for Z‑score of deltaH3K4methyls 
signal is shown on the right. c Schematic representation of proposed patterns of nucleosome remodeling
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(Fig.  5c, d). Given that H3K27Ac and DHS are widely 
considered to be markers of active enhancers, it is inter-
esting to note that the size of the GR binding peak corre-
lates poorly with the “activation state” of the enhancer to 
which it binds (r2 = 0.18, data not shown).
Heatmaps in Fig. 4a–d illustrate the histone modifica-
tion signal in unstimulated cells (NoStim H3K4meth-
yls) corresponding to the k-means clusters described 
above. Using histone modification signal to approximate 
nucleosome position, as in Kundaje et  al. [7], we see 
that sites in every cluster have highly variable position 
of the signal maximum relative to the future GR bind-
ing site, that many sites demonstrate well-positioned 
and phased nucleosomes prior to GR binding, and that 
signal is again asymmetric. At a minority of sites, a peak 













































































Fig. 4 Four distinct modes of nucleosome remodeling. Representative signal profiles of k‑means clusters belonging to each mode of remodeling 
(a central; b non‑central; c phased; d minimal). deltaH3K4methyls (red), GR (green), and deltaMNase (black) signals are overlaid for comparison. 
deltaMNase signal is magnified eightfold to facilitate visual comparison. Heatmaps illustrate nucleosome positioning prior to GR binding (NoStim 
H3K4methyls signal). Red box overlying heatmap of cluster 12 highlights evidence of well‑positioned, phased nucleosomes in the unstimulated 
condition
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binding, suggesting a well-positioned nucleosome that is 
displaced by GR. Strikingly, evidence of phased nucleo-
some positioning can be seen in the majority of clusters 
(Fig. 4b, red box), but pre-existing phased positioning is 
not more prevalent among sites showing phased remod-
eling. In other words, the pattern of nucleosome remod-
eling correlates poorly with the pattern of nucleosome 
position at enhancers prior to GR binding.
Central nucleosome remodeling increases positioning 
of flanking nucleosomes and suggests nucleosome 
eviction
Nucleosome remodeling that overlaps transcription fac-
tor binding, which we call “central” remodeling, has been 
previously described. For example, in their study of AR-
modulated nucleosome remodeling, He et  al. describe 


































































































































Fig. 5 Four modes of remodeling describe distinct subsets of GR peaks and enhancers. a Box and whisker plot of relative GR peak size reveals sig‑
nificant differences in GR peak size associated with each mode of remodeling. For all box and whisker plots, hinges of box are at located at 1st and 3rd 
quartiles. Whiskers extend to 1.5x interquartile range (IQR). Dots represent outlier observations. Notches signify an estimated 95 % confidence inter‑
val around the median. P‑values estimated by Kolmogorov–Smirnov test using all GR peaks as reference distribution. b Frequency of GRE sequence 
motifs among different modes of remodeling. Modes differ significantly in their pre‑existing enhancer strength, as measured by degree of H3K27Ac 
(c) and proportion of DHS (d). p‑values for (b, d) calculated by Fisher’s exact test
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signal. In their analysis, three well-positioned nucle-
osomes having similar occupancy were present prior to 
androgen stimulation, one directly overlying, and two 
immediately flanking the AR binding site. AR bind-
ing was shown to result in destabilization of the central 
nucleosome and stabilization of flanking nucleosomes 
without changes in flanking nucleosome position [12, 
18].
Our clustering analysis reveals that considerable diver-
sity of nucleosome position, occupancy, and remod-
eling underlies the central mode of remodeling. GR 
binding diminishes occupancy of one to three underly-
ing nucleosomes. Flanking nucleosomes become more 
precisely positioned and have stable or decreased occu-
pancy (Fig. 6a, left panel). In many cases, flanking nucle-
osomes also undergo positional shifts, widening the 
NDR to accommodate GR binding (Fig. 6a, right panel). 
In aggregate, we see diminished central ChIP-Seq sig-
nal without corresponding increases in signal of flank-
ing nucleosomes, suggesting that nucleosome eviction, 
rather than repositioning, predominates within this cen-
tral mode of remodeling.
Non‑central remodeling and cooperating transcription 
factors
Our clustering analysis reveals a large number of GR 
binding sites having changes in the deltaH3K4methyls 
signal that do not overlap the GR peak, but occur within 
1500 bp. As seen in Fig. 3, this “non-central” remodeling 
occurs asymmetrically, at variable distances from the 
GR binding site, in nearly half of GR binding instances 
(49  %). Sites of non-central remodeling increase the 
positioning of flanking nucleosomes without increas-
ing their occupancy, again suggesting nucleosome evic-
tion (Fig.  6b). We hypothesized that the asymmetry of 
non-central remodeling might have functional signifi-
cance. In other words, we hypothesized that non-central 
remodeling accompanies the binding of one or more GR 
cofactors and that choice of cofactor is impacted by DNA 
sequence. For each individual GR binding region dem-
onstrating non-central remodeling (denoted by asterisk 
symbol in Fig.  6b), we extracted the DNA sequence(s) 
having decreased H3K4methyls signal without colocal-
ized GR binding. Motif analysis of these sequences shows 
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Fig. 6 Nucleosome positioning and occupancy changes in modes of remodeling. Overlaid signal profiles of unstimulated (blue) and dexameth‑
asone‑stimulated (red) H3K4methyls as well as GR signal (green) in two representative clusters having central remodeling (a), non‑central remod‑
eling (b), or phased remodeling (c). Asterisk symbol in b denotes the regions used for motif analysis of DNA sequences associated with non‑central 
nucleosome eviction (d). Asterisk symbol in d denotes members of the ETS family of transcription factors. e Venn diagram of regions of non‑central 
remodeling relative to PU. 1 ChIP‑Seq peaks in unstimulated and dexamethasone‑stimulated cells
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RUNX1 transcription factor binding motifs (Fig.  6d). 
Several members of the ETS family have previously been 
reported to bind GR and other nuclear hormone recep-
tors and are thought to serve both pioneering and tether-
ing functions [27, 28].
We sought to validate that sites of non-central nucleo-
some remodeling are inducibly bound by a GR cofactor 
matching the predicted motifs. We performed ChIP-Seq 
for PU.1 (SPI1), which is essential for B cell differentia-
tion, and one of the most highly expressed members of 
the ETS family in pre-B cells [29]. The overlap between 
non-centrally remodeled regions and PU.1 binding sites is 
illustrated in Fig. 6e. It is difficult to determine the biolog-
ical or statistical significance of this degree of dexameth-
asone-induced PU.1 binding at these sites. To attempt 
this, we looked at all ETS binding motifs lying within the 
3-kb window surrounding all GR summits. We then sub-
tracted the regions binding GR itself. PU.1 exhibits dex-
amethasone-inducible binding at 1.9 % of all ETS motifs, 
but 4.5 % of the subset of ETS motifs having non-central 
nucleosome remodeling. These findings are consistent 
with our hypothesis that decreases in H3K4methyls signal 
largely reflect transcription factor binding, both for GR 
and PU.1, and perhaps more generally. Several additional 
members of the ETS family of transcription factors are 
expressed in B cells, and these may account for an even 
larger proportion of the non-centrally remodeled regions.
Phased nucleosome remodeling and nucleosome 
repositioning
Approximately 6  % of GR binding sites demonstrate 
a pattern of remodeling that can also be described as 
“phased”, where the deltaK4methyls signal shows distinct, 
alternating peaks and valleys. Phased remodeling sites 
are not the most highly “activated” enhancers (Fig. 5b, c), 
having lower H3K27Ac and DHS than sites of non-cen-
tral remodeling. Nonetheless, they have the largest GR 
peaks, as well as increased width and depth of the central 
nucleosome-depleted region (Figs.  5a, 6c). The phased 
appearance of remodeling reflects shifts in the position of 
two or more nucleosomes flanking the GR binding site. 
These flanking nucleosomes also become more precisely 
positioned and show stable or increased H3K4methyls 
signal, implying that phased remodeling reflects nucleo-
some repositioning, rather than eviction. Unlike other 
modes of remodeling, the total H3K4methyls signal at 
sites of phased remodeling increases, suggesting recruit-
ment of histone methyltransferases or displacement of 
histone demethylases (data not shown).
Minimal remodeling and de novo enhancer development
Regions lacking enhancer marks comprise the major-
ity of sites having minimal remodeling upon GR binding 
(57  %). The remaining regions of minimal remodeling 
also have low levels of enhancer activation, bearing less 
H3K27Ac and DHS relative to other modes of remode-
ling (Fig.  5b, c). Given their relatively small GR binding 
peaks and low pre-existing enhancer activity, we postu-
lated that sites of minimal remodeling could include sites 
of pioneering by GR, areas of GR ChIP-Seq artifact, or a 
mixture of both. In light of this concern, it is important to 
recognize that the weak histone modification signals seen 
prior to GR binding severely limit the sensitivity of our 
deltaH3K4methyls approach to detecting nucleosome 
remodeling. Notably, a substantial minority of minimally 
remodeled GR binding sites (32 %) specifically gain H3K4 
methylation at nucleosomes flanking the GR peak, sug-
gesting that these regions may be developing into de 
novo enhancers. Such developing enhancers could be 
considered “GR-specific”, defined only in response to GR 
binding.
Phased nucleosome remodeling is associated with rapid 
enhancer activation
We next asked whether the modes of nucleosome remod-
eling are associated with differential enhancer activation 
by measuring changes in DHS and H3K27Ac at GR bind-
ing sites (Fig. 7a, b). Both measures of enhancer activa-
tion demonstrate significant differences between modes 
of remodeling. Phased remodeling occurs at the most 
“dynamic” enhancers, gaining the largest proportion of 
DHS and showing the greatest gains in H3K27Ac. Cen-
tral remodeling is associated with modest gains in DHS. 
Although some enhancers having central remodeling gain 
degrees of H3K27Ac similar to the most highly activated 
phased remodeling sites, on average, central remod-
eling is associated with modest increases in H3K27Ac. 
Despite occurring at the most highly activated pre-exist-
ing enhancers, non-central remodeling regions gain rela-
tively little DHS, and the majority of sites show decreased 
H3K27Ac. Sites of minimal remodeling show very little 
change in DHS and relatively small gains and losses of 
H3K27Ac. Upon closer examination, we find that 32  % 
of minimal remodeling sites specifically gain H3K27Ac 
at nucleosomes flanking the GR peak. Altogether, more 
than half of all minimal remodeling regions gain one or 
more enhancer-associated marks (53 %, Fig. 7c), further 
stimulating our interest in the import of these regions as 
emerging enhancers.
Modes of nucleosome remodeling have functionally 
distinct effects on gene expression
Finally, we wished to evaluate the relationships between 
GR-associated nucleosome remodeling and changes in 
gene expression. We measured transcript abundance 
by microarray at 0, 8, and 24  h after stimulation with 
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Fig. 7 Modes of nucleosome remodeling have functionally distinct effects on enhancer activation and gene expression. Enhancer activation 
differs significantly between remodeling modes, as measured by proportion of sites gaining DHS (a) and degree of change in H3K27Ac (b). c Venn 
diagram of minimally remodeled GR binding sites and subsets which gain H3K4methylation, H3K27Ac, or DHS suggesting de novo enhancer devel‑
opment. d Box and whisker plot of log2 fold‑change expression for genes induced following dexamethasone treatment. Asterisk symbol indicates that 
phased remodeling is associated with significantly greater induction of gene expression than other modes of remodeling. e Box and whisker plot 
of log2 fold‑change expression for genes repressed following dexamethasone treatment. For d and e, p‑values estimated by Mann–Whitney test. 
n.s. denotes p‑value not significant. f GREAT (genomic regions enrichment of annotations tool) [30] analysis of GR sites having minimal remodeling. 
Gray text denotes gene ontologies not relevant to this cell type. Genes belonging to overlapping enrichment terms are listed on the right
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dexamethasone. We used the assumption that each GR 
binding peak is most likely to modulate expression of the 
nearest gene (transcriptional start site within 500  kb). 
This distance constraint associates nearly all peaks with 
a gene (95 %), and many genes have multiple associated 
peaks (40  %). For genes associated with multiple proxi-
mal GR peaks, we considered only those genes for which 
all peaks have the same mode of remodeling. As seen 
in Fig. 7d, e, many genes that do not show proximal GR 
binding at the 1-hour ChIP-Seq time point are differen-
tially expressed at the 8-hour microarray time point. This 
is consistent with known roles of many additional tran-
scription factor pathways in the glucocorticoid response 
as well as probable changes in GR binding at later time 
points.
Phased remodeling is associated with the most signifi-
cant induction of gene expression, and very few genes 
(<9 %) having proximal phased sites show decreased gene 
expression. Central, non-central, and minimal remod-
eling are also significantly associated with induction of 
gene expression relative to genes without proximal GR 
peaks. Remarkably, genes associated with minimally 
remodeled sites are induced as strongly as those hav-
ing central or non-central remodeling. In contrast, 
only non-central remodeling is associated with genes 
repressed more significantly than genes having no proxi-
mal GR binding. In examining gene expression at the 
24-h time point, we again find that each mode of remod-
eling remains significantly associated with induced gene 
expression, but none are associated with repression.
Finally, we used the Genomic Regions Enrichment of 
Annotations Tool (GREAT, [30]) to apply gene expres-
sion-based gene ontologies in a “pathway” analysis of GR 
binding sites for each mode of remodeling. The peaks 
associated with phased, central, or non-central remod-
eling each yield a large number of similar enrichment 
terms most notable for lymphocyte activation (Addi-
tional file  1). However, GREAT analysis of minimally 
remodeled peaks yields a small and distinctive subset of 
ontology terms that include decreased B cell number, B 
cell differentiation, and inhibition of the mTOR signal-
ing pathway (Fig. 7f ). This remarkable pathway specificity 
supports our hypothesis that the minimally remodeled 
GR binding sites, containing de novo and “GR-specific” 
enhancers, modulate expression of a distinctive subset of 
genes. Moreover, the associated genes and pathways have 
been previously shown to modulate both glucocorticoid-
induced cell death and the effectiveness of ALL therapy 
[31, 32].
Conclusions
Many groups have demonstrated well-positioned nucle-
osomes in relation to transcriptional start sites and RNA 
polymerase II binding in eukaryotic cells [4–7, 17, 33]. 
More recently, well-positioned nucleosomes have also 
been described at mammalian enhancers and in relation 
to transcription factor binding sites [6, 7]. These elegant 
and far-reaching studies have established a paradigm of 
precise nucleosomal organization at transcriptional regu-
latory elements influenced by several factors, including 
DNA sequence preferences for nucleosome occupancy, 
transcription factor binding, and “statistical packing”.
Much less is understood about the dynamics of nucleo-
some organization and their relationships to transcrip-
tional regulation. He et  al. investigated nucleosome 
dynamics relative to chromatin binding by androgen 
receptor and used H3K4me2 ChIP-Seq to describe nucle-
osome depletion overlapping transcription factor bind-
ing that is similar to the “central” mode of remodeling we 
define here [12]. This change in ChIP-Seq signal approxi-
mates increased DHS, which correlates with enhancer 
activation and induction of gene expression. Here we 
describe an approach to analyzing ChIP-Seq data that 
reveals considerably more complexity to nucleosome 
dynamics at transcription factor binding sites than has 
been previously appreciated. We have identified four 
functionally distinct modes of nucleosome remodeling 
that we have dubbed “central”, “non-central”, “phased”, 
and “minimal”.
We find that sites of central remodeling are charac-
terized by (1) predominant eviction, rather than repo-
sitioning, of nucleosomes; (2) increased positioning of 
flanking nucleosomes, and (3) frequent shifts in position 
of flanking nucleosomes. Non-central remodeling sites 
are defined by GR-proximal nucleosome eviction not 
overlapping the GR peak. We propose that this nucleo-
some eviction reflects binding of transcriptional cofac-
tors, exemplified by the ETS-family member PU.1, which 
can serve as both pioneer factor and tethering factor for 
GR. Interestingly, sites of non-central remodeling are also 
enriched for RUNX1 binding motifs. RUNX1 transloca-
tions producing chimeric fusion proteins with the ETS-
family transcription factor ETV6 are found in 20–25 % of 
childhood ALL and are associated with a favorable prog-
nosis, whereas RUNX1 amplifications are seen in ~2 % of 
childhood ALL and are associated with high-risk disease 
[34, 35]. Moreover, RUNX1 and PU.1 physically interact, 
and cooperate to modulate corepressor and coactivator 
recruitment, making the potential role(s) of RUNX1 in 
the GR transcriptional program an intriguing avenue for 
future study [36].
Many sites of non-central remodeling show decreased 
H3K27Ac, and a subset shows modest correlation with 
repression of gene expression. Given the many prior 
studies showing association of increased H3K27Ac, 
enhancer activation, and induction of gene expression 
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[37], it is tempting to speculate that loss of H3K27Ac is 
associated with enhancer “deactivation” and repression of 
gene expression. Like other groups, we find that the cor-
relation between decreased H3K27Ac and gene expres-
sion (r2 = 0.14) is poor relative to its converse (r2 = 0.41) 
[38]. We think it likely that a multivariate approach will 
be needed to better understand enhancer characteristics 
closely associated with transcriptional repression.
A minority of GR binding events is accompanied by a 
phased pattern of nucleosome remodeling character-
ized by predominant repositioning, rather than evic-
tion, of central nucleosomes. This repositioning results 
in increased occupancy and positioning of one or more 
nucleosomes flanking the GR binding site. Phased remod-
eling is not only associated with enhancer activation via 
increased H3K27Ac, but also with rapid induction of 
proximal gene expression. Given the previously reported 
dependence of dexamethasone-induced gene expression 
on the SWI/SNF chromatin remodeling complex [19, 20], 
it is tempting to speculate that SWI/SNF activity is par-
ticularly important for phased remodeling. We hope to 
address this hypothesis in future experiments.
Finally, we define a subset of GR binding sites char-
acterized by minimal nucleosome remodeling that is 
highly enriched for non-enhancer and weak enhancer 
regions. Many of these regions acquire H3K4methyla-
tion, H3K27Ac, and/or DHS only upon dexamethasone 
stimulation and GR binding, suggesting that GR can act 
as a true pioneer factor. We speculate that sites of pio-
neering represent de novo, “GR-specific” enhancers and 
speculate that they are among the most important for the 
leukemia cell death effect of glucocorticoid treatment. 
Contrary to the prevailing logic, our hypothesis suggests 
that the critical components of glucocorticoid-mediated 
transcriptional modulation are among the weakest GR 
binding sites, weakest enhancers, and least dynamic 
regions of early nucleosome remodeling. However, it is 
consistent with observations that prolonged glucocor-
ticoid exposure is required to induce apoptosis in many 
ALL cell lines [39] and that gene expression changes in 
glucocorticoid-treated cells show complex kinetics [40]. 
It will be fascinating to follow a time-course of ChIP-
Seq and gene expression to understand how the evolving 
enhancer landscape relates to changes in transcription.
In summary, we have developed a novel method for using 
histone modification-directed ChIP-Seq to reveal dynamic 
nucleosome occupancy and position and describe, for 
the first time, functionally distinct modes of nucleosome 
remodeling upon chromatin binding by GR. Our approach 
can be readily adapted to study nucleosome and enhancer 
dynamics mediated by other transcription factors, and we 
look forward to a burgeoning understanding of how nucle-
osome remodeling affects gene expression.
Methods
Cell lines and cell culture
The RS4;11 cell line was obtained from ATCC (CRL-
1873). Cultures were maintained at a density of 
1.5–3 × 106 cells/mL of medium (RPMI, 10 % FBS, 1 % 
penicillin/streptomycin). Two days prior to each experi-
ment, cells were transferred to RPMI medium contain-
ing 10 % charcoal-dextran treated serum (CDT, Omega), 
again supplemented with 1  % penicillin/streptomycin. 
For dexamethasone treatment, cells were adjusted to a 
density of 2 × 106 cells/mL in CDT-containing medium 
and treated by addition of 1 mM dexamethasone (Sigma) 
dissolved in 100  % ethanol for a final dexamethasone 
concentration of 10  nM and a final ethanol content of 
0.001 %. Dexamethasone treatment duration was 1 h for 
ChIP-Seq and DNase-Seq experiments.
Gene expression analysis
For gene expression experiments, cells were treated with 
dexamethasone as above for 0, 8, or 24 h. Five replicates 
were performed for each time point. RNA was isolated 
using Qiagen RNeasy Plus Mini columns. Transcripts 
were quantitated via hybridization to Agilent hgu133a2 
microarrays. Quality control assessment of microarray 
data was performed using the arrayQualityMetrics [41] 
package. Based upon these results, one of the unstimu-
lated (0  h time point) replicates was excluded from 
subsequent analyses. Normalization and background cor-
rection were performed using the rma algorithm of the 
affy package [42]. Non-specific filtering was performed 
using the genefilter package [43] with a variance cutoff of 
0.5, retaining 9953 of the initial 22,277 probe values. A 
single expression value for each gene at each time point 
was assigned using the mean of all corresponding probe 
values.
Antibodies
For ChIP-Seq experiments, antibodies against the follow-
ing targets were as follows: GR (1:1:1 mixture of Novus, 
NB300-731; Cell Signaling, D8H2; Abcam ab3579), PU.1 
(1:1:1 mixture of Pierce, E.388.3; Cell Signaling 2266; 
Santa Cruz Biotechnology SC-352X), H3K4me1 (Abcam, 
ab8895), H3K4me2 (Millipore, 07-030), H3K4me3 
(Abcam, ab8580), H3K27Ac (Abcam, ab4729).
Chromatin immunoprecipitation, histone modifications
Isolation of nuclei was performed by sucrose gradi-
ent centrifugation as previously described [44]. Nuclei 
(5  ×  107 cells) were resuspended in 5  mL of MNase 
digestion buffer (50  mM Tris–HCl, 320  mM sucrose, 
4 mM MgCl2, 1 mM CaCl2, pH 7.6). For digestion, 10 μL 
of MNase (New England Biolabs) was added and nuclei 
incubated at 37 °C for 2′45′′. Digestion was then stopped 
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by addition of 100 μL of 0.5 M EDTA. Nuclei were pel-
leted and DNA-containing supernatant was removed. 
The remaining nuclear pellet was resuspended in 500 μL 
of 1  mM Tris–HCl, 0.2  mM EDTA, pH 7.6 and incu-
bated at 4 °C for 30 min to extract larger DNA fragments. 
Nuclei were again pelleted and this supernatant was 
combined with the previous one. 100 μL of supernatant 
was removed from each sample and saved as input DNA 
for later analysis. The remaining supernatant was diluted 
eightfold using N-ChIP dilution buffer (50 mM Tris–HCl, 
50 mM NaCl, 5 mM EDTA, pH 7.5; protease inhibitors). 
One-fourth of the diluted supernatant was used for each 
IP by addition of 20 μL antibody-coated protein G Dyna-
beads (Invitrogen) followed by incubation overnight at 
4 °C. Chromatin-containing beads were isolated by mag-
netic separation and serially washed with 1 mL of cold (1) 
low-salt wash buffer (20  mM Tris–HCl, 150  mM NaCl, 
2 mM EDTA, 0.1 % SDS, 1 % Triton X-100, pH 8.1; pro-
tease inhibitors), (2) high-salt wash buffer (20 mM Tris–
HCl, 500 mM NaCl, 2 mM EDTA, 0.1 % SDS, 1 % Triton 
X-100, pH 8.1; protease inhibitors), (3) LiCl wash buffer 
(10 mM Tris–HCl, 250 mM LiCl, 1 mM EDTA, 1 % IGE-
PAL-CA630, 1 % sodium deoxycholate, pH 8.1; protease 
inhibitors), and (4) Tris–EDTA buffer. Beads were resus-
pended in 100  μL of elution buffer (100  mM NaHCO3, 
1 % SDS). Input and ChIP samples were then subjected 
to RNase digestion by addition of 4 μL of 5 M NaCl and 
1 μL DNase-free RNase A (10 mg/mL; Life Technologies) 
with incubation at 56  °C for 30  min. Protein digestion 
was then accomplished by addition of 1 μL proteinase K 
(NEB) and further incubation at 56 °C for 1 h. DNA was 
isolated using Qiagen MinElute PCR Purification Kit per 
manufacturer’s directions.
Chromatin immunoprecipitation, transcription factors
For ChIP of transcription factor targets (GR, PU. 1), 
cells were resuspended in fixing buffer (50 mM HEPES, 
100  mM NaCl, 0.8  mM EDTA, 0.5  mM EGTA, pH 7.6; 
protease inhibitors) at a concentration of 5 ×  106  cells/
mL. Fixation was accomplished by addition of EGS (eth-
ylene glycol-bis(succinic acid N-hydroxysuccinimide 
ester), 1.5  mM final concentration, Sigma) with incuba-
tion at room temperature for 30 min, followed by addi-
tion of formaldehyde (1 % final v/v ratio), and incubation 
at room temperature for 10  min. Quenching and isola-
tion of nuclei were performed as previously described 
[45]. Nuclei were resuspended in cold sonication buffer 
(50 mM Tris–HCl, 1 mM EDTA, 0.5 % SDS, pH 7.6) at a 
concentration of 75 × 106 cells/mL. 25 × 106 cells were 
placed in each sonication tube (Covaris, Cat. 520056) 
and sonicated using a Covaris E220 Focused Ultrasonica-
tor (duty cycle 20 %, intensity 10, pulse time 3 min × 6 
pulses). 10 μL of sonicated chromatin was removed from 
each sample and saved as input DNA for later analy-
sis. Sonicated samples were then diluted fivefold with 
RIPA buffer. Immunoprecipitation was done by addi-
tion of 100  μL antibody-coated protein G Dynabeads 
(Invitrogen) followed by incubation overnight at 4  °C. 
Chromatin-containing beads were isolated by magnetic 
separation and serially washed three times with 1 mL of 
cold high-salt LiCl buffer (100  mM Tris–HCl, 500  mM 
LiCl, 1 % IGEPAL-CA630, 1 % deoxycholate, pH 7.6) fol-
lowed by 1 mL of cold TE. Elution, RNA digestion, and 
protein digestion were performed as described above. 
Reversal of cross-linking was done by incubation at 65 °C 
overnight, followed by DNA isolation as described above.
DNase hypersensitivity
Isolation of nuclei for DNase hypersensitivity assays 
was performed by sucrose gradient centrifugation as 
described above with the addition of 0.15 mM spermine 
and 0.05 % spermidine to buffers. The nuclear pellet was 
resuspended in DNase digestion buffer (40  mM Tris–
HCl, 10 mM NaCl, 6 mM MgCl2, 1 mM CaCl2, pH 7.9) 
at a concentration of 5 ×  106  cells/mL. DNase (Roche) 
digestion was performed using five different enzyme con-
centrations (40, 50, 60, 75, 90 U/mL) for each sample by 
incubation at 37 °C for 5 min. An additional cell sample 
was incubated without addition of exogenous DNase. 
Digestion was stopped by addition of an equal volume 
of stop-lysis buffer (50  mM Tris–HCl, 600  mM NaCl, 
100 mM EDTA, 1 % SDS, pH 7.9). For sequencing pur-
poses, 5  μg of genomic DNA isolated from the control 
sample was digested in a volume of 50 μL using 4 U/mL 
of DNase. This control digestion was stopped by adding 
5  μL of 25  mM EDTA. DNA was isolated by phenol–
chloroform extraction and ethanol precipitation.
Library amplification and sequencing
Prior to library amplification, adequacy of DNA frag-
mentation (via MNase digestion, DNase digestion, or 
sonication) was verified by visualization on a 2 % agarose 
E-Gel (Life Technologies). DNA was size-selected using 
a Pippin Prep agarose gel system (2 % agarose, Sage Sci-
ence) with an average fragment size of 150 bp for MNase-
digested samples, 200  bp for sonicated samples, and 
75 bp for DNase-digested samples. DNA yield was quan-
tified using Quant-iT PicoGreen reagent (Life Technolo-
gies) and NanoDrop 3300 fluorospectrometer (Thermo 
Scientific). 1–2  ng of size-selected DNA was used for 
each library. ChIP DNA was end-repaired and adenylated 
as previously described [46]. Adenylated DNA fragments 
were ligated to Illumina TruSeq multiplexed adapters. 
Adapter-ligated DNA was then amplified using Phusion 
high-fidelity DNA polymerase (New England Biolabs) 
with TruSeq PCR primers (final concentration 0.5 mM) 
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using the following thermocycler conditions: 98 °C × 30′; 
7–9 cycles of 98  °C  ×  10′, 65  °C  ×  30′, 72  °C  ×  30′; 
72  °C  ×  5  min. Single-end, 50  bp sequencing was per-
formed at The Center for Cancer Computational Biology 
(Dana-Farber Cancer Institute, Boston, MA) using an 
Illumina HiSeq instrument.
Data analysis
Sequences were aligned to the hg19 genome assembly 
with Bowtie 0.12.8 allowing one sequence mismatch and 
requiring unique alignments [47]. Peak-calling was per-
formed with MACS1.4 using default settings, including 
unique read requirement and p value threshold of 1 × 10−5 
[48]. Genome distribution of GR ChIP-Seq peaks was 
analyzed using the CEAS package [49]. Non-normalized 
ChIP-Seq signal files (.wig format) were also generated 
using MACS1.4. Signal files were then normalized using 
the ZScore tool of the Java Genomics Toolkit (JGK), creat-
ing wig files having global mean of 0 and global standard 
deviation of 1 [50]. These normalized ChIP-Seq signal files 
were used for all subsequent analyses. deltaH3K4me1, del-
taH3K4me2, deltaH3K4me3, and deltaH3K27Ac files were 
created using the JGK Subtract tool and the deltaK4meth-
yls file was created using the JGK Add tool. For visualiza-
tion purposes, signal files were smoothed using the JGK 
GaussianSmooth tool with standard deviation of 20  bp. 
Motif analyses were performed using Haystack [51]. Area-
under-the-curve measurements were performed using the 
WiggleTools package [52]. Gene ontology analyses were 
performed using the GREAT package [30].
K-means clustering was performed using the com-
puteMatrix and heatmapper functions of deepTools [53]. 
We first estimated an appropriate k value by plotting the 
total within-groups sum of squares against the number of 
centroids, using a range of 5–80 centroids. Based upon 
this curve, we estimated that 25–30 centroids would pro-
vide a good fit to the data. As described by Kundaje et al. 
[7], we found that “anchoring” our signal window around 
the summit of the GR ChIP-Seq peak, rather than the 
center of a canonical GR binding motif, generated more 
reproducible clustering results.
In generating figures, we used the multiIntersectBed 
tool of the BEDTools2 package [54] and eulerAPE [55] to 
create Venn diagrams. Genome browser snapshots were 
generated using the Integrated Genome Viewer (IGV) 
[56]. Heatmaps and signal profiles were generated using 
deepTools. All other charts were generated using the 
ggplot2 package [57]. Statistical tests were performed 
using the stats package [58].
Availability of supporting data
All microarray and sequencing data have been depos-
ited in GEO (and SRA) with reference series GSE71617, 
comprised of subseries GSE71615 (microarray) and 
GSE71616 (ChIP-Seq and DHS).
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